PTPRC and Splenomegaly: Consistently, mice bearing SHQ1-deficient cells manifested ameliorated splenomegaly and more reddish bones (Fig. 4d), as well as suppressed CD45+ leukemia cell dissemination in the BM and spleen (Fig. 4e, f).